Skip to main content
. Author manuscript; available in PMC: 2020 Mar 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2018 Nov 10;103(4):861–868. doi: 10.1016/j.ijrobp.2018.11.004

Fig. 1.

Fig. 1.

(A) Overall survival (OS) and progression-free survival (PFS) for the 85 eligible patients; (B) OS (P=.064) and PFS (P=.068) stratified by gender; (C) OS (P=.009) and PFS (P=.050) stratified by tumor size (<5 cm vs. ≥5 cm)(D) OS (P=.010) and PFS (P=.54) stratified by histology (PA vs. other) for the 72 centrally reviewed patients